Wealthsource Partners, LLC Eli Lilly & CO Transaction History

Wealthsource Partners, LLC

$1.52 Billion
Q4 2023

A detailed history of Wealthsource Partners, LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Wealthsource Partners, LLC holds 4,332 shares of LLY stock, worth $3.42 Million. This represents 0.17% of its overall portfolio holdings.

Number of Shares

4,332

Previous 4,864 10.94%

Holding current value

$3.42 Million

Previous $2.61 Million 3.33%

% of portfolio

0.17%

Previous 0.18%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Jan 12, 2024	SELL	$525.19 - $619.13 $279,401 - $329,377	-532 Reduced 10.94%	4,332 $2.53 Million
Q3 2023 Nov 09, 2023	SELL	$434.7 - $599.3 $72,594 - $100,083	-167 Reduced 3.32%	4,864 $2.61 Million
Q2 2023 Aug 14, 2023	SELL	$350.74 - $468.98 $21,745 - $29,076	-62 Reduced 1.22%	5,031 $2.36 Million
Q1 2023 May 15, 2023	BUY	$310.63 - $364.82 $1,553 - $1,824	5 Added 0.1%	5,093 $1.75 Million
Q4 2022 Feb 09, 2023	SELL	$321.55 - $374.67 $257,561 - $300,110	-801 Reduced 13.6%	5,088 $1.86 Million
Q3 2022 Nov 14, 2022	SELL	$296.48 - $337.87 $171,958 - $195,964	-580 Reduced 8.97%	5,889 $1.9 Million
Q2 2022 Aug 10, 2022	SELL	$278.73 - $327.27 $283,189 - $332,506	-1,016 Reduced 13.57%	6,469 $2.1 Million
Q1 2022 May 09, 2022	SELL	$234.69 - $291.66 $29,101 - $36,165	-124 Reduced 1.63%	7,485 $2.14 Million
Q4 2021 Feb 14, 2022	SELL	$224.85 - $279.04 $26,307 - $32,647	-117 Reduced 1.51%	7,609 $2.1 Million
Q3 2021 Nov 18, 2021	BUY	$221.6 - $272.71 $312,234 - $384,248	1,409 Added 22.3%	7,726 $1.79 Million
Q2 2021 Nov 18, 2021	BUY	$180.55 - $233.54 $7,763 - $10,042	43 Added 0.69%	6,317 $1.45 Million
Q1 2021 Jun 21, 2021	BUY	$164.32 - $212.72 $12,981 - $16,804	79 Added 1.28%	6,274 $1.17 Million
Q4 2020 Feb 12, 2021	SELL	$130.46 - $172.63 $42,008 - $55,586	-322 Reduced 4.94%	6,195 $1.05 Million
Q3 2020 Nov 16, 2020	BUY	$146.22 - $169.13 $16,522 - $19,111	113 Added 1.76%	6,517 $964,000
Q2 2020 Aug 17, 2020	BUY	$136.42 - $164.18 $21,554 - $25,940	158 Added 2.53%	6,404 $1.05 Million
Q1 2020 May 12, 2020	BUY	$119.05 - $147.35 $22,500 - $27,849	189 Added 3.12%	6,246 $866,000
Q4 2019 Feb 12, 2020	SELL	$106.92 - $132.43 $49,183 - $60,917	-460 Reduced 7.06%	6,057 $796,000
Q3 2019 Nov 15, 2019	BUY	$106.79 - $116.16 $115,546 - $125,685	1,082 Added 19.91%	6,517 $729,000
Q2 2019 Aug 09, 2019	BUY	$110.79 - $129.32 $602,143 - $702,854	5,435 New	5,435 $602,000

Others Institutions Holding LLY

# of Institutions

4,007

Shares Held

752M

Call Options Held

8.27M

Put Options Held

10.5M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $750B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wealthsource Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wealthsource Partners, LLC with notifications on news.

Account

Wealthsource Partners, LLC Eli Lilly & CO Transaction History